Melanoma Survivor Shares Story to Encourage Pittsburghers to Prioritize Skin Health
UNITED STATES, JUL 18 – A genetically modified herpesvirus combined with nivolumab shrank tumors by 30% in one-third of advanced melanoma patients, with FDA review expected by July 2025.
4 Articles
4 Articles
Can Herpes Help Fight Late Stage Melanoma?
Scientists are working to harness the power of the herpesvirus responsible for cold sores in order to treat a deadly cancer: late-stage melanoma . About half of people with this advanced form of skin cancer run out of viable treatment options, says Gino In, MD, MPH , a coauthor of the study and an associate professor and oncologist with Keck Medicine of USC in Los Angeles. But in recent clinical trials, a genetically modified herpesvirus (in com…
Case Study: Sarah’s Journey with High-Burden BRAF V600E Melanoma
This is an actor portrayal of a hypothetical patient profile developed for educational purposes based on characteristics of patients with multiple myeloma as seen in clinical practice. The hypothetical case was co-developed by staff medical writers with Cancer Network/ONN.
Case Study: Sarah’s Journey With High-Burden BRAF V600E Melanoma
This is an actor portrayal of a hypothetical patient profile developed for educational purposes based on characteristics of patients with multiple myeloma as seen in clinical practice. The hypothetical case was co-developed by staff medical writers with Cancer Network/ONN.
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium